Radiotherapy and Oncology
Volume 147, 2020, Pages 100-102
Wei, Wei; Jiang, Hao; Chen, Weipeng; Zhou, Yuling; Guo, Shuanshuan; Zhong, Guihua; Zhou, Huaili; Wang, Siyang; Zhang, Hongyu; Jiang, Wen; Liu, Zhi-gang.
Letter to the Editor
Since December 2019, an increasing number of cases of the2019 novel coronavirus disease (COVID-19) infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been identified in Wuhan, a large city of 11 million people in centralChina[1,2]. By February 19, 2020, the rapid spread of the virus had caused 74,280 cases and 2,009 deaths in China. Most cases were identified in Hubei Province, followed by bordering provinces, such as Guangdong Province, Henan Province, Hunan Province, and Anhui Province.
Keywords
COVID-19, SARS-CoV-2, Treatment